{"nct_id":"NCT01945775","title":"A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)","status":"COMPLETED","status_verified_date":"2021-12","start_date":"2013-10-14","start_date_type":"ACTUAL","primary_completion_date":"2017-09-15","primary_completion_date_type":"ACTUAL","completion_date":"2021-03-05","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PFE"]}